Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending July 27, 2024 (Week 30)
Reporting Area Carbapenemase-Producing Organisms (CPO), Total §,¶
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 21 NC 2,162 3,259
New England - NC 31 33
Connecticut - NC - -
Maine - NC 3 -
Massachusetts - NC - -
New Hampshire - NC 8 14
Rhode Island - NC 20 19
Vermont - NC - -
Middle Atlantic 3 NC 75 319
New Jersey - NC - -
New York (excluding New York City) - NC - -
New York City - NC - 125
Pennsylvania 3 NC 75 194
East North Central 12 NC 1,122 1,016
Illinois - NC 10 58
Indiana - NC 165 221
Michigan 2 NC 85 175
Ohio 10 NC 862 542
Wisconsin - NC - 20
West North Central - NC 66 91
Iowa - NC 13 40
Kansas - NC 49 49
Minnesota - NC - -
Missouri - NC - -
Nebraska - NC - -
North Dakota - NC - 2
South Dakota - NC 4 -
South Atlantic 6 NC 309 479
Delaware - NC 13 5
District of Columbia - NC - -
Florida N NC N N
Georgia - NC - 189
Maryland - NC - -
North Carolina - NC - 95
South Carolina - NC - -
Virginia 6 NC 239 147
West Virginia - NC 57 43
East South Central - NC - 100
Alabama N NC N N
Kentucky - NC - -
Mississippi - NC - 100
Tennessee - NC - -
West South Central - NC - 13
Arkansas - NC - -
Louisiana - NC - 13
Oklahoma - NC - -
Texas U NC U U
Mountain - NC 545 464
Arizona - NC 531 444
Colorado - NC - -
Idaho - NC - -
Montana - NC 5 1
Nevada - NC 1 6
New Mexico - NC - -
Utah - NC 8 12
Wyoming - NC - 1
Pacific - NC 14 744
Alaska - NC - -
California - NC - 712
Hawaii - NC - 5
Oregon - NC 14 11
Washington - NC - 16
U.S. Territories - NC - 113
American Samoa - NC - -
Commonwealth of Northern Mariana Islands - NC - -
Guam - NC - -
Puerto Rico - NC - 113
U.S. Virgin Islands - NC - -
Non-U.S. Residents - NC 1 -
Total 21 NC 2,163 3,372
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2023, cases began to be reported as Carbapenemase-Producing Organisms, clinical or Carbapenemase-Producing Organisms, screening. In previous years, only Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) cases were reported.
  • ¶ CPO (total) includes CP-CRE cases reported in MMWR year 2023, and CPO clinical and CPO screening cases reported in both MMWR years 2023 and 2024.